Similarly, skin biopsies in AD patients have shown marked local reductions in expression of type 2 inflammatory pathway genes, including the STAT6‐regulated genes eotaxin‐3, TARC and PARC (CCL‐18).30, 31. The gene discussed is CCL26; the disease is Alzheimer disease.